Fluzone High-Dose was 24.2% more effective in preventing influenza in adults aged 65 years or older than regular Fluzone in a large-scale clinical trial, vaccine maker Sanofi Pasteur told the Advisory ...

FDA approves Fluzone ® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older *Will be available in fall 2020, in time for the 2020-2021 flu season PARIS - November 4, 2019 – ...

Fluzone (influenza vaccine) is safe to receive while pregnant or breastfeeding. Certain factors, including the risks of getting influenza (the flu) during pregnancy, may determine whether you should ...

Not known whether Fluzone Quadrivalent is excreted in human milk. Consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for Fluzone Quadrivalent and any ...

The US Food and Drug Administration (FDA) has approved Fluzone (Sanofi) high-dose quadrivalent influenza vaccine for adults aged 65 years and older. This approval is the final step toward the ...

The FDA approved a supplemental Biologic License Application for the Fluzone High-Dose Quadrivalent vaccine for the prevention of influenza in adults aged 65 years or older, Sanofi announced.

Fluzone is a brand-name vaccine used to help prevent certain types of flu. Fluzone comes in two forms: Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent. Fluzone’s cost with and without ...

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license ...

Sanofi Pasteur has launched its first consumer advertising for Fluzone Intradermal, featuring a prickly pitch-critter meant to stress the flu vaccine’s extra-thin needle. Henry the Porcupine, an ...

PARIS - November 4, 2019 – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in ...

PARIS, Nov. 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for ...